CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-15 | Stamoulis Christiana EVP & Chief Financial Officer | Shares withheld for taxes | −3,672 | $72.46 | $266K | 91,525 |
| 2025-01-15 | Stein Steven H EVP & Chief Medical Officer | Shares withheld for taxes | −10,692 | $72.46 | $775K | 79,319 |
| 2025-01-06 | Issa Mohamed Khairie EVP, Head of US Oncology | Grant or award | +48,671 | 48,671 | ||
| 2024-12-31 | BAKER BROS. ADVISORS LP Director | Grant or award | +446 | 2,813,405 | ||
| 2024-12-31 | BAKER BROS. ADVISORS LP Director | Grant or award | +446 | 28,184,084 | ||
| 2024-12-31 | Clancy Paul J Director | Grant or award 10b5-1 | +331 | $69.07 | $23K | 19,713 |
| 2024-12-31 | HARRIGAN EDMUND Director | Grant or award 10b5-1 | +339 | $69.07 | $23K | 17,071 |
| 2024-12-16 | Tray Thomas Principal Accounting Officer | Sale 10b5-1 | −650 | $69.31 | $45K | 23,312 |
| 2024-12-13 | Tray Thomas Principal Accounting Officer | Sale 10b5-1 | −650 | $70.64 | $46K | 23,962 |
| 2024-12-09 | SWAIN PAULA J EVP, Human Resources | Shares withheld for taxes | −873 | $72.11 | $63K | 85,203 |
| 2024-12-09 | Flannelly Barry P EVP & General Manager US | Shares withheld for taxes | −1,510 | $72.11 | $109K | 56,532 |
| 2024-11-29 | Iyengar Vijay K EVP, GMAPPS | Sale 10b5-1 | −360 | $75.60 | $27K | 36,341 |
| 2024-11-29 | Iyengar Vijay K EVP, GMAPPS | Sale 10b5-1 | −5,683 | $75.37 | $428K | 30,658 |
| 2024-11-06 | Flannelly Barry P EVP & General Manager US | Option exercise 10b5-1 | +1,424 | $72.27 | $103K | 59,466 |
| 2024-11-06 | Flannelly Barry P EVP & General Manager US | Option exercise 10b5-1 | +2,256 | $68.62 | $155K | 61,722 |
| 2024-11-06 | Flannelly Barry P EVP & General Manager US | Sale 10b5-1 | −1,424 | $82.00 | $117K | 60,298 |
| 2024-11-06 | Flannelly Barry P EVP & General Manager US | Sale 10b5-1 | −2,256 | $78.21 | $176K | 58,042 |
| 2024-11-06 | Flannelly Barry P EVP & General Manager US | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,424 | 0 | ||
| 2024-11-06 | Flannelly Barry P EVP & General Manager US | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −2,256 | 0 | ||
| 2024-10-02 | Denton Sheila A. EVP & General Counsel | Shares withheld for taxes | −2,136 | $67.63 | $144K | 30,343 |
Page 24 of 25 · 500 trades